Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Papanas, N ^a   Demetriou, M ^a   Katsiki, N ^b   Papatheodorou, K ^a   Papazoglou, D ^a   Gioka, T ^c   Kotsiou, S ^a   Maltezos, E ^a   Mikhailidis, D P ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; URIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SUDOMOTOR DYSFUNCTION; SWEAT GLAND DISEASE; SWEATING; URIC ACID BLOOD LEVEL; AGED; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY; SECRETION; SWEAT;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; SWEAT; SWEATING; URIC ACID;

EID: 81555225317     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/346051     Document Type: Article

References (44)

1. Ziegler D., Zental C. P., Perz S., Rathmann W., Haastert B., Dring A., Meisinger C., Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort study Diabetes Care 2008 31 3 556 561
2. Vinik A. I., Maser R. E., Ziegler D., Neuropathy: the crystal ball for cardiovascular disease? Diabetes Care 2010 33 7 1688 1690
3. Low V. A., Sandroni P., Fealey R. D., Low P. A., Detection of small-fiber neuropathy by sudomotor testing Muscle and Nerve 2006 34 1 57 61
4. Yano K., Reed D. M., McGee D. L., Ten-year incidence of coronary heart disease in the Honolulu heart program. Relationship to biologic and lifestyle characteristics American Journal of Epidemiology 1984 119 5 653 666 (Pubitemid 14142804)
5. Freedman D. S., Williamson D. F., Gunter E. W., Byers T., Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study American Journal of Epidemiology 1995 141 7 637 644
6. Moriarity J. T., Folsom A. R., Iribarren C., Nieto F. J., Rosamond W. D., Serum uric acid and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study Annals of Epidemiology 2000 10 3 136 143 (Pubitemid 30171270)
7. Fang J., Alderman M. H., Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National health and nutrition examination survey JAMA Journal 2000 283 18 2404 2410 (Pubitemid 30257539)
8. Mazza A., Pessina A. C., Pavei A., Scarpa R., Tikhonoff V., Casiglia E., Predictors of stroke mortality in elderly people from the general population. The Cardiovascular Study in the ELderly European Journal of Epidemiology 2001 17 12 1097 1104
9. Daskalopoulou S. S., Athyros V. G., Elisaf M., Mikhailidis D. P., Uric acid levels and vascular disease Current Medical Research and Opinion 2004 20 6 951 954 (Pubitemid 38821534)
10. Edwards N. L., The role of hyperuricemia in vascular disorders Current Opinion in Rheumatology 2009 21 2 132 137
11. Milionis H. J., Kalantzi K. J., Goudevenos J. A., Seferiadis K., Mikhailidis D. P., Elisaf M. S., Serum uric acid levels and risk for acute ischaemic nonembolic stroke in elderly subjects Journal of Internal Medicine 2005 258 5 435 441 (Pubitemid 41546559)
12. Karagiannis A., Mikhailidis D. P., Tziomalos K., Sileli M., Savvatianos S., Kakafika A., Gossios T., Krikis N., Moschou I., Xochellis M., Athyros V. G., Serum uric acid as an independent predictor of early death after acute stroke Circulation Journal 2007 71 7 1120 1127 (Pubitemid 46998030)
13. Baker J. F., Schumacher H. R., Krishnan E., Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial Angiology 2007 58 4 450 457 (Pubitemid 47301052)
14. Shankar A., Klein B. E., Nieto F. J., Klein R., Association between serum uric acid level and peripheral arterial disease Atherosclerosis 2008 196 2 749 755 (Pubitemid 351146654)
15. Katsiki N., Athyros V. G., Karagiannis A., Mikhailidis D. P., Hyperuricaemia and non-alcoholic fatty liver disease (nafld): a relationship with implications for vascular risk? Current Vascular Pharmacology. In press
16. Papazafiropoulou A., Tentolouris N., Moyssakis I., Perrea D., Katsilambros N., The potential effect of some newer risk factors for atherosclerosis on aortic distensibility in subjects with and without type 2 diabetes Diabetes Care 2006 29 8 1926 1928 (Pubitemid 44156656)
17. Lehto S., Niskanen L., Rnnemaa T., Laakso M., Serum uric acid is a strong predictor of stroke in patients with noninsulin-dependent diabetes mellitus Stroke 1998 29 3 635 639 (Pubitemid 28145791)
18. Tseng C. H., Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes Diabetic Medicine 2004 21 7 724 729
19. Papanas N., Katsiki N., Papatheodorou K., Demetriou M., Papazoglou D., Gioka T., Maltezos E., Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus Angiology 2011 62 4 291 295
20. Lanza G. A., Pitocco D., Navarese E. P., Sestito A., Sgueglia G. A., Manto A., Infusino F., Musella T., Ghirlanda G., Crea F., Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade European Heart Journal 2007 28 7 814 820 (Pubitemid 47343595)
21. Huang L.-L., Huang C.-T., Chen M.-L., Mao I.-F., Effects of profuse sweating induced by exercise on urinary uric acid excretion in a hot environment Chinese Journal of Physiology 2010 53 4 254 261
22. Daskalopoulou S. S., Tzovaras V., Mikhailidis D. P., Elisaf M., Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia Current Pharmaceutical Design 2005 11 32 4161 4175 (Pubitemid 41679180)
23. Athyros V. G., Mikhailidis D. P., Liberopoulos E. N., Kakafika A. I., Karagiannis A., Papageorgiou A. A., Tziomalos K., Ganotakis E. S., Elisaf M., Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek atorvastatin and coronary heart disease evaluation (GREACE) study Nephrology Dialysis Transplantation 2007 22 1 118 127 (Pubitemid 46050336)
24. Athyros V. G., Elisaf M., Papageorgiou A. A., Symeonidis A. N., Pehlivanidis A. N., Bouloukos V. I., Milionis H. J., Mikhailidis D. P., Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study American Journal of Kidney Diseases 2004 43 4 589 599 (Pubitemid 38401873)
25. Papanas N., Papatheodorou K., Christakidis D., Papazoglou D., Giassakis G., Piperidou H., Monastiriotis C., Maltezos E., Evaluation of a new indicator test for sudomotor function (Neuropad ) in the diagnosis of peripheral neuropathy in type 2 diabetic patients Experimental and Clinical Endocrinology and Diabetes 2005 113 4 195 198 (Pubitemid 40695323)
26. Papanas N., Ziegler D., New diagnostic tests for diabetic distal symmetric polyneuropathy Journal of Diabetes and its Complications 2011 25 1 44 51
27. Joint National Committee, The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report Journal of the American Medical Association 2003 289 19 2560 2572
28. Blackburn H., Keys A., Simonson E., Rantaharju P., Punsar S., The electrocardiogram in population studies. A classification system Circulation 1960 21 1160 1175
29. Molitch M. E., DeFronzo R. A., Franz M. J., Diabetic nephropathy. Position statement Diabetes Care 2003 26 supplement 1 S94 S98
30. Fong D. S., Aiello L., Gardner T. W., Diabetic retinopathy. Position statement. Clinical practice recommendations 2003 Diabetes Care 2003 26 supplement 1 S99 S102
31. Herder C., Lankisch M., Ziegler D., Rathmann W., Koenig W., Illig T., Dring A., Thorand B., Holle R., Giani G., Martin S., Meisinger C., Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA survey F 3 (Augsburg, Germany) Diabetes Care 2009 32 4 680 682
32. Gonzlez-Clemente J. M., Vilardell C., Broch M., Megia A., Caixs A., Giménez-Palop O., Richart C., Simn I., Martnez-Riquelme A., Arroyo J., Mauricio D., Vendrell J., Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes European Journal of Endocrinology 2007 157 1 31 38 (Pubitemid 47162563)
33. Strazzullo P., Puig J. G., Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutrition, Metabolism and Cardiovascular Diseases 2007 17 409 414
34. So A., Thorens B., Uric acid transport and disease Journal of Clinical Investigation 2010 120 6 1791 1799
35. Vincent A. M., Hayes J. M., McLean L. L., Vivekanandan-Giri A., Pennathur S., Feldman E. L., Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1 Diabetes 2009 58 10 2376 2385
36. Wiggin T. D., Sullivan K. A., Pop-Busui R., Amato A., Sima A. A. F., Feldman E. L., Elevated triglycerides correlate with progression of diabetic neuropathy Diabetes 2009 58 7 1634 1640
37. Tesfaye S., Chaturvedi N., Eaton S. E., Ward J. D., Manes C., Ionescu-Tirgoviste C., Witte D. R., Fuller J. H., Vascular risk factors and diabetic neuropathy New England Journal of Medicine 2005 352 4 341 350
38. Papanas N., Papatheodorou K., Papazoglou D., Kotsiou S., Maltezos E., A prospective study on the use of the indicator test Neuropad for the early diagnosis of peripheral neuropathy in type 2 diabetes Experimental and Clinical Endocrinology and Diabetes 2011 119 2 122 125
39. Papanas N., Paschos P., Papazoglou D., Accuracy of the neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes Diabetes Care 2011 34 1378 1382
40. Ziegler D., Papanas N., Roden M., Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabetic Medicine. In press
41. Vincent A. M., Hinder L. M., Pop-Busui R., Feldman E. L., Hyperlipidemia: a new therapeutic target for diabetic neuropathy Journal of the Peripheral Nervous System 2009 14 4 257 267
42. Gde P., Vedel P., Larsen N., Jensen G. V., Parving H. H., Pedersen O., Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes New England Journal of Medicine 2003 348 5 383 393 (Pubitemid 36159355)
43. Fioretto P., Dodson P. M., Ziegler D., Rosenson R. S., Residual microvascular risk in diabetes: unmet needs and future directions Nature Reviews Endocrinology 2010 6 1 19 25
44. Tsouli S. G., Liberopoulos E. N., Mikhailidis D. P., Athyros V. G., Elisaf M. S., Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism: Clinical and Experimental 2006 55 10 1293 1301 (Pubitemid 44354944)